CYTOSTATIC THERAPY OF NEPHROTIC SYNDROME WITH MINIMAL CHANGES IN CHILDREN AND ADOLESCENTS
https://doi.org/10.24884/1561-6274-2004-8-2-98-105
Abstract
Cytostatic therapy of nephrotic syndrome with minimal changes in children and adolescents.
About the Authors
I. V. Batrakova
Санкт-Петербургская государственная педиатрическая медицинская академия
Russian Federation
Russian Federation
N. D. Savenkova
Санкт-Петербургская государственная педиатрическая медицинская академия
Russian Federation
Russian Federation
References
1. International Study of Kidney Disease in Children. The nephrotic syndrome in children: prediction of histopathological from clinical and laboratory characteristics of time of diagnosis. Kidney Int 1978; 13:159
2. APN Argeitsgemeinschaft fur Padiatrische Nephrologie. Short versus standart prednisolone therapy for initial treatment of idiopatic nephrotic syndrome in children. Lancet 1988; 1: 380383
3. Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. СОТИС, СПб; 1997
4. Вargman JM. Management of minimal lesion glomerulonephritis. Evidencebased recommendations. Kidney Int 1999; 55 [Suppl 70]: 316
5. Савенкова НД, Папаян АВ. Нефротический синдром в практике педиатра. Эскулап, СПб, 1999; 256
6. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98 (4): 561564
7. Barratt TM, Clark G. Minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Pediatric nephrology. Baltimor et al. 1994; 767787
8. Clark A, Barratt TM. Steroid – responsive nephrotic syndrome. In: Barratt TM, Avner ED, Harman WE. Pediatric nephrology 1998; 731747
9. Brodehl J. Conventional therapy for minimal change nephrotic syndrome. Clin Nephrol 1991; 35 (1): 815
10. Калиничева ЕО, Папаян АВ. Функциональная активность гипофизарногонадной и гипофизарнонадпочечни ковой систем у детей с нефротическим синдромом с минимальными изменениями. Материалы I конгресса педиатровнефрологов России, 1719 сентября 1996, СПб; 113 121
11. Савенкова НД. Терапия дебюта рецидивирующего гормонзависимого, гормонорезистентного и со стероид ной токсичностью вариантов нефротического синдрома с минимальными изменениями у детей (лекция). Материалы 1 конгресса педиатровнефрологов России, 1719 сентября 1996, СПб.; 153164
12. Савенкова НД, Папаян АВ. Современная стратегия нефротического синдрома с минимальными изменениями у детей. Материалы Российского Конгресса «Современные методы диагностики и лечения в детской нефрологии и урологии». Москва 2002; 4549
13. Игнатова МС, Курбанова ЭГ. Иммуносупрессивная терапия нефротического синдрома у детей. Novartis М. 2000;103
14. Grup W, Makker SP, Ingelfinger JR. Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 1976; 295: 746749
15. Pennisi AJ, Grushkin CM, Lieberman E. Cyclophosphamid in the treatment of idiopathic nephrotic syndrome. Pediatrics 1976; 57: 948951
16. International Study of Kidney Disease in Children: Prospective, controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet 1974; 2: 423427
17. Argeitsgemeinschaft fur Padiatrische Nephrologie: Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course. Arch Dis Child 1987; 62: 11021106
18. Ueda N, Kuno K, Ito S. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. Arch Dis Child 1990; 85: 11471150
19. Takeda A, Ohgushi, Minura F: Longterm effect of immunosuppressant in steroid – dependent nephrotic syndrome. Pediatr Nephrol 1998; 12(9): 746750
20. Kemper MJ, Altrogge H, Lundwig K et al. Unfarvorable response to cyclophosphamide in steroid dependent nephrotic syndrome. Pediatr Nephrol 2000; 14(89): 772775
21. Vester U, Kranz B, Zimmermann S, Hoyer P. Cyclophosphamide in frequently relapsing and steroid dependent nephrotic syndrome: Abstracts The 12 the Congress of the International Pediatric Nephrology Association. Pediatr Nephrol 2001; 16(8): 258
22. Ponticelli C, Edefonti A, Ghio L et al. Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326–1332
23. Настаушева ТЛ, Ситникова ВП, Стешинская EB, Cтaxурлова ЛИ. Иммуносупрессивная терапия гломеруло нефрита у детей цитостатическими препаратами алкили рующего действия. Нефрология и диализ 2000; 2(4): 291292
24. Батракова ИВ. Особенность рецидивов нефротического синдрома у детей, имеющих повышение специфи ческого Ig E к аллергенам. Материалы III Конгресса педиатровнефрологов России. 2003; СПб: 9596
25. Игнатова МС. Сандиммун – неорал при лечении не фротического синдрома у детей. В: Руководство по фарма котерапии в педиатрии и детской хирургии, том 3 Нефрология, МедпрактикаМ, М., 2003; 7884
26. Краснова ТН. Особенности течения и лечения нефротического синдрома у больных гломерулонефритами. ООО «Издательство Триада», Тверь, 2003; 40
27. Ponticelli C, Edefonti A, Ghio L et al. Cyclosporin versus cyclophosphamide for patients with steroid dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326–1332
28. Rinaldi S, Sesto A, Barsotti P et al. Longterm cyclosporine treatment in children with steroiddependent nephrotic syndrome a clinical and histologic analysis. Nephrol Dial Transplant 2003; 18 [Suppl 4]: 262
29. Inou Y, Iijima K, Nakamura H, Yoshikava N. Twoyear cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1999; 13: 3338
30. Matsamoto H, Hakao T, Okada T et al. Initial remission inducing effect of very lowolose cyclosporin monotherapy for minimalchange nephrotic syndrome in Japannese adults. Clin Nephrol 2001; (55)2: 143148
31. Tanaka R, Yoshikawa N, Kitano Y. Longterm cyclosporin treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1999; 7:249252: 3338
32. Tendron A, Gouyon J, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol 2002; 17(2): 121130
33. Yocota S. Mizoribine: Mode of action and effects in clinical use. Pediatrics Int 2002; 44:196198
34. Dayton JS, Turka LA, Thompson CB, Mitchell BS. Comparison of the effects of mizoribine with those of azathioprine, 6mercaptopurine and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 1992; 41: 6716
35. Honda M. Nephrotic syndrome and mizoribine in children. Pediatrics Int 2002; 44:196198
36. Kobayashi Y, Kamiyama Y, Honda M et al. The effect of mizoribine in children frequent relapsing nephrotic syndrome. Jpn J Nephrol 1992; 34:537
37. Igarashi Y, Moro Y, Kondo Y, Inoue CN. Steroidsparing effect of mizoribine in longterm nephrotic syndrome of children. Pediatr Nephrol 1994; 8: 3967
38. Hamasaki T, Mori M, Kinoshita Y. Mizoribine in steroid dependent nephrotic syndrome of childhood. Pediatr Nephrol 1997; 11: 6257
39. Yoshioka K, Ohashi Y, Sacai T et al. A multicenter trial of mizoribine compared with placebo in children in frequently relapsing idiopathic nephrotic syndrome. Kidney Int 2000; 58: 31724
40. Ulinski Т, Ranchin B, Said MH et al. Switch from cyclosporin A (Cy A) to mycophenolate mofetil improves kidney function in children with nephrotic syndrome and Cy Ainduced nephrotoxicity. Nephrol Dial Transplant 2003;18 [Suppl 4]: 261
41. Hogg R, Fizgibbons L, Bruick J et al. Multicenter trial of mycophenolate mofetil (MMF) in children with steroid dependent (SD) or frequent relapsing (FR) nephrotic syndrome (NS). Report of the southwest pediatric nephrology study group. Nephrol Dial Transplant 2003;18 [Suppl 4]: 261
Review
For citations:
Batrakova I.V., Savenkova N.D. CYTOSTATIC THERAPY OF NEPHROTIC SYNDROME WITH MINIMAL CHANGES IN CHILDREN AND ADOLESCENTS. Nephrology (Saint-Petersburg). 2004;8(2):98-105. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-2-98-105
Views:
422
Email this article 